APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amlodipine Besylate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amlodipine Besylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchAmlodipine Besylate Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Amlodipine Besylate Tablets Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Amlodipine Besylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amlodipine Besylate Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Amlodipine Besylate Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Amlodipine Besylate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amlodipine Besylate Tablets include AstraZeneca, Bristol-Myers Squibb, North China Pharmaceutical, China Resources Double-Crane Pharmaceutical, Pfizer, Jingfeng Pharmaceutical, Roche, Sanofi and Shanghai Shyndec Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amlodipine Besylate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amlodipine Besylate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amlodipine Besylate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amlodipine Besylate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Amlodipine Besylate Tablets Segment by Company

AstraZeneca

Bristol-Myers Squibb

North China Pharmaceutical

China Resources Double-Crane Pharmaceutical

Pfizer

Jingfeng Pharmaceutical

Roche

Sanofi

Shanghai Shyndec Pharmaceutical

Yangtze River Pharmaceutical

Amlodipine Besylate Tablets Segment by Type

5 Milligrams

10 Milligrams

Amlodipine Besylate Tablets Segment by Application

Hospital

Pharmacy

Amlodipine Besylate Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amlodipine Besylate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Amlodipine Besylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Amlodipine Besylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Amlodipine Besylate Tablets Industry Trends Table 2. Amlodipine Besylate Tablets Industry Drivers Table 3. Amlodipine Besylate Tablets Industry Opportunities and Challenges Table 4. Amlodipine Besylate Tablets Industry Restraints Table 5. Global Amlodipine Besylate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Amlodipine Besylate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Amlodipine Besylate Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers Table 9. Global Amlodipine Besylate Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Amlodipine Besylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Amlodipine Besylate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Amlodipine Besylate Tablets Manufacturers, Product Type & Application Table 13. Global Amlodipine Besylate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Amlodipine Besylate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5 Milligrams Table 17. Major Manufacturers of 10 Milligrams Table 18. Global Amlodipine Besylate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Amlodipine Besylate Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Amlodipine Besylate Tablets Sales Market Share by Type (2021-2026) Table 22. Global Amlodipine Besylate Tablets Sales Market Share by Type (2027-2032) Table 23. Global Amlodipine Besylate Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Amlodipine Besylate Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Amlodipine Besylate Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Pharmacy Table 30. Global Amlodipine Besylate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 32. Global Amlodipine Besylate Tablets Sales by Application (2027-2032) & (K Units) Table 33. Global Amlodipine Besylate Tablets Sales Market Share by Application (2021-2026) Table 34. Global Amlodipine Besylate Tablets Sales Market Share by Application (2027-2032) Table 35. Global Amlodipine Besylate Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Amlodipine Besylate Tablets Revenue by Application (2021-2026) & (K Units) Table 37. Global Amlodipine Besylate Tablets Revenue by Application (2027-2032) & (K Units) Table 38. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Amlodipine Besylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Amlodipine Besylate Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Amlodipine Besylate Tablets Sales Market Share by Region (2021-2026) Table 43. Global Amlodipine Besylate Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Amlodipine Besylate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 47. North America Amlodipine Besylate Tablets Sales by Country (2027-2032) & (K Units) Table 48. Europe Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 50. Europe Amlodipine Besylate Tablets Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Amlodipine Besylate Tablets Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2027-2032) & (K Units) Table 57. Global Amlodipine Besylate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Amlodipine Besylate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Amlodipine Besylate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2027-2032) Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca Amlodipine Besylate Tablets Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Bristol-Myers Squibb Company Information Table 68. Bristol-Myers Squibb Business Overview Table 69. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio Table 71. Bristol-Myers Squibb Recent Development Table 72. North China Pharmaceutical Company Information Table 73. North China Pharmaceutical Business Overview Table 74. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 76. North China Pharmaceutical Recent Development Table 77. China Resources Double-Crane Pharmaceutical Company Information Table 78. China Resources Double-Crane Pharmaceutical Business Overview Table 79. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 81. China Resources Double-Crane Pharmaceutical Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Amlodipine Besylate Tablets Product Portfolio Table 86. Pfizer Recent Development Table 87. Jingfeng Pharmaceutical Company Information Table 88. Jingfeng Pharmaceutical Business Overview Table 89. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 91. Jingfeng Pharmaceutical Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Roche Amlodipine Besylate Tablets Product Portfolio Table 96. Roche Recent Development Table 97. Sanofi Company Information Table 98. Sanofi Business Overview Table 99. Sanofi Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sanofi Amlodipine Besylate Tablets Product Portfolio Table 101. Sanofi Recent Development Table 102. Shanghai Shyndec Pharmaceutical Company Information Table 103. Shanghai Shyndec Pharmaceutical Business Overview Table 104. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 106. Shanghai Shyndec Pharmaceutical Recent Development Table 107. Yangtze River Pharmaceutical Company Information Table 108. Yangtze River Pharmaceutical Business Overview Table 109. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 111. Yangtze River Pharmaceutical Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Amlodipine Besylate Tablets Distributors List Table 115. Amlodipine Besylate Tablets Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Amlodipine Besylate Tablets Product Image Figure 2. Global Amlodipine Besylate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amlodipine Besylate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Amlodipine Besylate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Amlodipine Besylate Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Amlodipine Besylate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5 Milligrams Image Figure 9. 10 Milligrams Image Figure 10. Global Amlodipine Besylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Amlodipine Besylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Amlodipine Besylate Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Amlodipine Besylate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Amlodipine Besylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Pharmacy Image Figure 18. Global Amlodipine Besylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Amlodipine Besylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Amlodipine Besylate Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Amlodipine Besylate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Amlodipine Besylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Amlodipine Besylate Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Amlodipine Besylate Tablets Sales Market Share by Country (2021-2032) Figure 38. China Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Amlodipine Besylate Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Amlodipine Besylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Amlodipine Besylate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Amlodipine Besylate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Amlodipine Besylate Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Amlodipine Besylate Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Amlodipine Besylate Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Amlodipine Besylate Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Amlodipine Besylate Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Amlodipine Besylate Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5 Milligrams
  • 10 Milligrams
Applications
  • Hospital
  • Pharmacy
Companies covered
  • AstraZeneca
  • Bristol-Myers Squibb
  • North China Pharmaceutical
  • China Resources Double-Crane Pharmaceutical
  • Pfizer
  • Jingfeng Pharmaceutical
  • Roche
  • Sanofi
  • Shanghai Shyndec Pharmaceutical
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amlodipine Besylate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amlodipine Besylate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Amlodipine Besylate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Amlodipine Besylate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Amlodipine Besylate Tablets Market Dynamics
  1. 2.1 Amlodipine Besylate Tablets Industry Trends
  2. 2.2 Amlodipine Besylate Tablets Industry Drivers
  3. 2.3 Amlodipine Besylate Tablets Industry Opportunities and Challenges
  4. 2.4 Amlodipine Besylate Tablets Industry Restraints
3 Amlodipine Besylate Tablets Market by Manufacturers
  1. 3.1 Global Amlodipine Besylate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Amlodipine Besylate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Amlodipine Besylate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Amlodipine Besylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amlodipine Besylate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Amlodipine Besylate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Amlodipine Besylate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amlodipine Besylate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amlodipine Besylate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amlodipine Besylate Tablets Tier 1, Tier 2, and Tier 3
4 Amlodipine Besylate Tablets Market by Type
  1. 4.1 Amlodipine Besylate Tablets Type Introduction
  2. 4.1.1 5 Milligrams
  3. 4.1.2 10 Milligrams
  4. 4.2 Global Amlodipine Besylate Tablets Sales by Type
  5. 4.2.1 Global Amlodipine Besylate Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amlodipine Besylate Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Amlodipine Besylate Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Amlodipine Besylate Tablets Revenue by Type
  9. 4.3.1 Global Amlodipine Besylate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amlodipine Besylate Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Amlodipine Besylate Tablets Revenue Market Share by Type (2021-2032)
5 Amlodipine Besylate Tablets Market by Application
  1. 5.1 Amlodipine Besylate Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Amlodipine Besylate Tablets Sales by Application
  5. 5.2.1 Global Amlodipine Besylate Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Amlodipine Besylate Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Amlodipine Besylate Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Amlodipine Besylate Tablets Revenue by Application
  9. 5.3.1 Global Amlodipine Besylate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Amlodipine Besylate Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Amlodipine Besylate Tablets Revenue Market Share by Application (2021-2032)
6 Global Amlodipine Besylate Tablets Sales by Region
  1. 6.1 Global Amlodipine Besylate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amlodipine Besylate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Amlodipine Besylate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Amlodipine Besylate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Amlodipine Besylate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Amlodipine Besylate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Amlodipine Besylate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Amlodipine Besylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Amlodipine Besylate Tablets Revenue by Region
  1. 7.1 Global Amlodipine Besylate Tablets Revenue by Region
  2. 7.1.1 Global Amlodipine Besylate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Amlodipine Besylate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Amlodipine Besylate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Amlodipine Besylate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Amlodipine Besylate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Amlodipine Besylate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Amlodipine Besylate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Amlodipine Besylate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Amlodipine Besylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 North China Pharmaceutical
  14. 8.3.1 North China Pharmaceutical Company Information
  15. 8.3.2 North China Pharmaceutical Business Overview
  16. 8.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  18. 8.3.5 North China Pharmaceutical Recent Developments
  19. 8.4 China Resources Double-Crane Pharmaceutical
  20. 8.4.1 China Resources Double-Crane Pharmaceutical Company Information
  21. 8.4.2 China Resources Double-Crane Pharmaceutical Business Overview
  22. 8.4.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  24. 8.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Jingfeng Pharmaceutical
  32. 8.6.1 Jingfeng Pharmaceutical Company Information
  33. 8.6.2 Jingfeng Pharmaceutical Business Overview
  34. 8.6.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  36. 8.6.5 Jingfeng Pharmaceutical Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Amlodipine Besylate Tablets Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Shanghai Shyndec Pharmaceutical
  50. 8.9.1 Shanghai Shyndec Pharmaceutical Company Information
  51. 8.9.2 Shanghai Shyndec Pharmaceutical Business Overview
  52. 8.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  54. 8.9.5 Shanghai Shyndec Pharmaceutical Recent Developments
  55. 8.10 Yangtze River Pharmaceutical
  56. 8.10.1 Yangtze River Pharmaceutical Company Information
  57. 8.10.2 Yangtze River Pharmaceutical Business Overview
  58. 8.10.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  60. 8.10.5 Yangtze River Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amlodipine Besylate Tablets Value Chain Analysis
  2. 9.1.1 Amlodipine Besylate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amlodipine Besylate Tablets Production Mode & Process
  6. 9.2 Amlodipine Besylate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amlodipine Besylate Tablets Distributors
  9. 9.2.3 Amlodipine Besylate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst